A股生物医药板块盘初拉升，瑞普生物涨超8%，*ST贤丰涨超3.5%，科兴制药、东方生物、科前生物、蔚蓝生物等跟涨。

Group 1 - The A-share biopharmaceutical sector experienced an initial surge, with Reap Bio rising over 8% [1] - ST Xianfeng increased by more than 3.5% [1] - Other companies such as Sinovac Biotech, Oriental Bio, KQ Biotech, and Blue Horizon Biotech also saw gains [1]